Prevalencija metaboličkog sindroma i njegova povezanost sa sociodemografskim karakteristikama odraslog stanovništva Banje Luke

  • Verica Petrović Health Center Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina
  • Gordana Tešanović Health Center Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina
  • Ljiljana Stanivuk University of Banja Luka, Faculty of Medicine, Banja Luka, Republic of Srpska, Bosnia and Herzegovina; Health Care Institute of Republic of Srpska, Banja Luka, Republic of Srpska, Bosnia and Herzegovina
Ključne reči: metabolički sindrom;, prevalenca;, socioekonomski faktori;, demografija;, životno doba, faktori;, obrazovanje.

Sažetak


Uvod/Cilj. Metabolički sindrom (MS) je skup metabo­ličkih i hemodinamskih poremećaja koji povećavaju rizik od ate­rosklerotskih kardiovaskularnih bolesti i dijabetes melitusa tipa 2. Cilj rada bio je da se utvrdi prevalencija MS i nje­govih komponenti kod odraslog stanovništva Banja Luke, kao i povezanost MS sa sociodemografskim karakte­ristikama. Metode. Analizirano je ukupno 685 ispitanika (348 muš­karaca i 337 žena), starosti 18 godina i više. MS je procenjivan na osnovu definicije Internacionalnog udru­ženja za dijabetes (International Diabetes Federation – IDF). Rezultati. Prevalencija MS bila je visoka (37,5%), nešto viša kod žena nego kod muškaraca, ali bez statistički značajne razlike (38,3% : 36,8%; p = 0.686). Zastupljenost svake pojedinačne komponente MS iznosila je preko 30% (sistolni krvni pritisak ≥ 130 mmHg – 42,0%; dijastolni krvni pritisak ≥ 85 mmHg – 31,0%; trigliceridi ≥ 1,7 mmol/L – 36,1%; lipoproteini velike gustine HDL holesterol < 1,03 muškarci i < 1,29 žene – 31,2%; glikemija ≥ 5,6 mmol/L – 32,8%; centralna gojaznost ≥ 94 cm muškarci i ≥ 80 cm žene – 62,6%). Pokazalo se da pojava MS u ispitivanoj grupi nije zavisila od pola, ali jeste od godina života. Sa povećanjem godina života zastupljenost ispitanika se povećavala u grupi sa MS (statistički značajna razlika u odnosu na grupu bez MS). Potvrđena je povezanost pojave MS sa stepenom obrazovanja. Nizak nivo obrazovanja bio je udružen sa pojavom MS [statistički značajna razlika (df = 3; p = 0.013)]. Udruženost između stepena obrazovanja i MS je potvđena kod žena (df = 3; p = 0.000), ali ne i kod muškaraca (df = 3; p = 0.883). Penzioneri i domaćice bili su statistički značajno zastupljeniji u grupi sa MS, a studenti i nezaposleni u grupi bez MS, dok kod zaposlenih nije bilo statistički značajne razlike. Zaključak. MS je zastupljen kod više od jedne trećine odraslog stanovništva Banja Luke. Pokazalo se da pojava MS nije zavisila od pola, ali je postojala zavisnost u odnosu na životno doba, stepen obrazovanja, kao i određenih kategorija radnog statusa.

Biografije autora

Verica Petrović, Health Center Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina

- porodična medicina

- doktor medicinskih nauka

Gordana Tešanović, Health Center Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina

- pedijatar

- doktor medicinskih nauka

Ljiljana Stanivuk, University of Banja Luka, Faculty of Medicine, Banja Luka, Republic of Srpska, Bosnia and Herzegovina; Health Care Institute of Republic of Srpska, Banja Luka, Republic of Srpska, Bosnia and Herzegovina

magistar medicinskih nauka

specijalista higijene

Reference

References:

Vishram JK, Borglykke A, Andreasen AH, Jeppesen J, Ibsen H, Jergensen T, et al. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Co-hort Project. PloS One 2014; 9(9): e107294

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosisand classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539–53.

National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106(25): 3143–421.

International diabetes federation. The IDF consensus world-wide definition of the metbolic syndrome. Brussels: IDF; 2006.

Alberti K. G, Eckel R.H, Grundy S.M, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16): 1640–5.

Stojisavljević D. The prevalence of metabolic syndrome in adult population of the Republic of Srpska [dissertation]. Belgrade: Faculty of Medicine, University of Belgrade; 2014. (Serbian)

Ivezić – Lalić D, Bergman Marković B, Kranjčević K, Kem J, Vrdoljak D, Vučak J. Diversity of metabolic syndrome criteria in association with cardiovascular diseases – a family medicine-based investigation. Med Sci Monit. 2013; 19: 571–8.

Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534906 individuals. J Am Coll Cardiol 2011; 57(11): 1299–313.

Corbatón-Anchuelo A, Martínez-Larrad MT, Fernández-Pérez C, Vega-Quiroga S, Ibarra-Rueda JM, Serrano-Rios M, et al. Metabolic syndrome, adiponectin, and cardiovascular risk in Spain (The Segovia Study): impact of consensus societies criteria. Metab Syndr Relat Disord 2013; 11(5): 309–18.

Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the Metabolic Syndrome in the United States, 2003-2012. JAMA. 2015; 313(19): 1973–4.

Al-Daghri NM, Alkharfy KM, Al-Attas OS, Khan N, Alfawaz HA, Alghanim SA, et al. Gender-dependent associations be-tween socioeconomic status and metabolic syndrome: a cross-sectional study in the adult Saudi population. BMC Car-diovasc Disord 2014; 14: 51.

Khan RJ, Gebreab SY, Sims M, Riestra P, Xu R, Davis SK. Prevalence, associated factors and heritabilities of metabolic syndrome and its individual components in African Americans: the Jackson Heart Study. BMJ Open 2015; 5(10): e008675.

Vidigal F de C, Ribeiro AQ, Babio N, Salas-Salvado J, Bressan J. Prevalence of metabolic syndrome and pre-metabolic syn-drome in health professionals: LATINMETS Brazil study. Di-abetol Metab Syndr 2015; 7: 6.

Kaur J. Assessment and Screening of the Risk Factors in Meta-bolic Syndrome. Med Sci 2014; 2(3): 140 ̶ 52.

Hajian-Tilaki K, Heidari B, Firouzjahi A, Baqherzadeh M, Hajian-Tilaki A, Halalkhor S. Prevalence of metabolic syndrome and the associated socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes Metab Syndr 2014; 8(3): 170–6.

Song QB, Zhao Y, Liu YQ, Zhang J, Xin SJ, Dong GH. Sex difference in the prevalence of metabolic syndrome and cardiovascular related risk factors in urban adults from 33 communities of China: The CHPSNE study. Diab Vasc Dis Res 2015; 12 (3): 189–98.

Objavljeno
2020/12/01
Rubrika
Originalni članak